ProCE Banner Events

Share

An Expert Guide to What’s New and What’s Next for Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma

Join us live in San Diego or online via simulcast for this live, 2-hour, interactive CME-certified Satellite Symposium where an expert panel will review the latest evidence to optimize the care of patients with relapsed/refractory follicular lymphoma, including discussion of patient cases and practical guidance on sequencing therapies. 

Throughout the symposium, learners will have the opportunity to directly text questions to the panel. Register now!

Friday Satellite Symposium on An Expert Guide to What’s New and What’s Next for Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma, preceding the 65th ASH Annual Meeting and Exposition

Physicians: maximum of 2.00 AMA PRA Category 1 Credits™

This event has expired. No longer available for credits.

Who Should Attend

This program is intended for physicians and other healthcare professionals who care for patients with relapsed/refractory follicular lymphoma.

Time and location

Friday, December 08, 2023

3:30 PM - 5:30 PM Pacific Time (PT)

In-personVirtual

Marriott Marquis San Diego Marina
333 W Harbor Dr.
San Diego, California 92101

Pacific Ballroom 18-19

Faculty
Peter Martin, MD

Chief, Lymphoma Program
Professor of Medicine
Weill Cornell Medicine
Meyer Cancer Center
New York, New York

Sonali M. Smith, MD, FASCO

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
The University of Chicago
Chicago, Illinois

Julie Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor
Chief, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Agenda

Registration & Refreshment: 3:00 PM - 3:30 PM PT

  • Welcome and Introduction
  • Overview and Unmet Needs in R/R FL
  • Panel Discussion and Case Studies: Patient Selection and Sequencing of New and Emerging Options For R/R FL
      • CAR T-Cell Therapy 
      • Bispecific Antibodies
      • Epigenetic Modifiers
  • Addressing Key Challenges and Future Directions in R/R FL
      • Clinical Trial Spotlight on Key FL Abstracts at ASH 2023
  • Audience Question and Answer Session

Location

Venue Name

Marriott Marquis San Diego Marina

Address

Marriott Marquis San Diego Marina
333 W Harbor Dr.
San Diego, California 92101

Room Name

Pacific Ballroom 18-19

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of physicians and other healthcare professionals to optimize diagnosis and management of patients with relapsed/refractory follicular lymphoma.

Target Audience
This program is intended for physicians and other healthcare professionals who care for patients with relapsed/refractory follicular lymphoma.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate currently available clinical data on novel targeted therapies to treat patients with relapsed/refractory follicular lymphoma
  • Plan the optimal sequence of antibodies, CAR T-cell therapy, or epigenetic modifiers for patients with relapsed/refractory follicular lymphoma based on available evidence, as well as guideline and expert recommendations
  • Identify patients with relapsed/refractory follicular lymphoma who are eligible for enrollment on a clinical trial

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from Genentech, a member of the Roche Group; Genmab; Ipsen Biopharmaceuticals, Inc; and Regeneron Pharmaceuticals, Inc.

Contact Information

For customer support please click here.

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.